About Huatai United Securities Co., Ltd
Comparison between the deposit and actual use of annual raised funds in 2021
Verification opinions
Huatai United Securities Co., Ltd. (hereinafter referred to as “Huatai United Securities” or “sponsor”) as the sponsor of Wuxi Apptec Co.Ltd(603259) (hereinafter referred to as ” Wuxi Apptec Co.Ltd(603259) ” or “company”) initial public offering of shares in 2018 and non-public offering of shares in 2020, in accordance with the administrative measures for securities issuance and listing recommendation business The guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies, the stock listing rules of Shanghai Stock Exchange and the guidelines for the self discipline supervision of listed companies of Shanghai Stock Exchange No. 1 – standardized operation and other relevant provisions have carefully verified the deposit and actual use of raised funds in Wuxi Apptec Co.Ltd(603259) 2021. The verification results and opinions are as follows:
1、 Basic information of raised funds
(I) funds raised from initial public offering of a shares
With the approval of the reply on approving Wuxi Apptec Co.Ltd(603259) initial public offering (zjxk [2018] No. 678) of China Securities Regulatory Commission (hereinafter referred to as “CSRC”), the company publicly issued 104198556 ordinary shares (A shares) in Shanghai Stock Exchange (hereinafter referred to as “Shanghai Stock Exchange”), with an issue price of 21.60 yuan per share, The total amount of funds raised from stock issuance is RMB 225068880960. After deducting the issuance expenses of RMB 12040340960, the actual net amount of funds raised is RMB 213028540000. The actual amount received is 216066125722 yuan, including 3037585722 yuan of other issuance expenses that have not been transferred (including 1251841465 yuan of other issuance expenses that have been paid from the company’s own capital account in the early stage and 1785744257 yuan of other issuance expenses that have not been paid). All the above-mentioned funds have been received on May 2, 2018, verified by Deloitte Touche Tohmatsu (special general partnership) and issued the capital verification report DSB (y) Zi (18) No. 00197.
As of December 31, 2021, the company has used a total of 149072241709 yuan of raised funds. The balance of unused raised funds is RMB 74896665936, of which RMB 22000000000 is used for cash management to purchase financial products, and RMB 52896665936 is deposited in the regulatory bank (including the net amount of interest income and financial income generated by raised funds after deducting bank renewal fees and others is RMB 10940367645).
As of December 31, 2021, the bank accounts of raised funds related to the funds raised by the initial public offering of a shares
The ending balance of the account is 52896665936 yuan in total. The specific deposit conditions are as follows:
Unit: RMB
Name of deposit bank name of deposit company name of account opening account number funds to May 2, 2018 initial deposit amount to December 31, 2021 deposit balance
Ping An Bank Co.Ltd(000001) shares 15062018041
Co., Ltd. Shanghai company 800564000 Ping An Bank Co.Ltd(000001) 65538614 branch business department
Shares
Shanghai Co., Ltd. 51090204101200000 Ping An Bank Co.Ltd(000001) 1061086 free trade test division 08022018
Bank business department may
Bank Of Communications Co.Ltd(601328) shares 322 Inner Mongolia Tianshou Technology&Development Co.Ltd(000611) 012
Wuxi Co., Ltd. 801803089166946145722638397304 helangkou sub branch
Shanghai Pudong Development 98460078801
Bank Co., Ltd. 7 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 617271998000043590070433 Baoshan sub branch
Shanghai Pudong development Suzhou Wuxi Apptec Co.Ltd(603259)
Bank Co., Ltd. new drug development Co., Ltd. 98460078801 – 4439764312 Baoshan sub branch company (“Suzhou pharmaceutical 2 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 93″)
(Ming)
Ping An Bank Co.Ltd(000001) shares Tianjin Wuxi Apptec Co.Ltd(603259)
Tianjin new drug development Co., Ltd. 150 Beijing Centergate Technologies (Holding) Co.Ltd(000931) 77 not applicable – 4051571260 Binhai sub branch company (“Tianjin Pharmaceutical 419”)
(Ming)
China Merchants Bank Co.Ltd(600036) shares Shanghai Wuxi Apptec Co.Ltd(603259)
Shanghai New Drug Development Co., Ltd. 51090204731 – 262927 free trade test division (“Shanghai Pharmaceutical 0103”)
Bank business department
Total 21606612572252896665936
Note: the ending balance includes the accumulated interest income and wealth management income received, and the net amount after deducting bank charges and others is RMB 10940367645.
(II) funds raised from non-public offering of A-Shares in 2020
With the approval of the reply on the approval of Wuxi Apptec Co.Ltd(603259) non-public offering of shares (zjxk [2020] No. 1828) issued by the CSRC, the company’s non-public offering shall not exceed
105000000 new shares with a par value of RMB 1.00 per share. The company’s non-public offering of 62690290 RMB ordinary shares at an issue price of 104.13 yuan per share. The total amount of funds raised from stock issuance is 652793989770 yuan. After deducting the issuance expenses of RMB 6669361226 (excluding tax), the net amount of actually raised funds is RMB 646124628544. After deducting the deductible VAT input tax of RMB 400161674 from the issuance expenses of this non-public offering and adding back the other issuance expenses of RMB 867980000 (including tax) that have not been transferred, the actual amount received is RMB 646592446870. The above actually raised funds of RMB 646592446870 have all arrived on September 8, 2020, and have been verified by Deloitte Huayong Certified Public Accountants (special general partnership) and issued a capital verification report of DSB (y) Zi (20) No. 00517.
As of December 31, 2021, the company has accumulated 519262118166 yuan of raised funds. The balance of the unused raised funds is 136213395195 yuan (including the interest income and wealth management income generated by the raised funds, and the net amount after deducting bank charges and others is 9350884817 yuan).
As of December 31, 2021, the ending balance of the bank account of the raised funds related to the non-public offering of A-Shares of the company in 2020 amounted to RMB 136213395195. The specific deposit conditions are as follows: unit: RMB
Name of deposit bank account opening company account opening account funds to September 8, 2020 initial deposit amount to December 31, 2021 deposit balance
Bank Of Communications Co.Ltd(601328) share ownership
Wuxi Hedong Company Limited 322 Inner Mongolia Tianshou Technology&Development Co.Ltd(000611) 01736280 Ping An Bank Co.Ltd(000001) 1264789489kou sub branch Shanghai Kaibao Pharmaceutical Co.Ltd(300039) 4273
Shanghai Pudong Development Bank
Bank Co., Ltd. 98460078801491760 Shenzhen Fountain Corporation(000005) 502469823 Baoshan sub branch 900 Ningxia Qinglong Pipes Industry Group Co.Ltd(002457)
Bank Of Communications Co.Ltd(601328) shares in 2020
Limited company Wuxi Hedong company 322 Inner Mongolia Tianshou Technology&Development Co.Ltd(000611) 01 September 8660640 Shenzhen Quanxinhao Co.Ltd(000007) 15350260kou sub branch Shanghai Kaibao Pharmaceutical Co.Ltd(300039) 5171
Bank Of Communications Co.Ltd(601328) share ownership
Wuxi Hedong Company Limited 322 Inner Mongolia Tianshou Technology&Development Co.Ltd(000611) 011789260 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 5662172105kou sub branch Shanghai Kaibao Pharmaceutical Co.Ltd(300039) 5247
Shanghai Pudong Development Bank
Bank Co., Ltd. 98460078801300 Ping An Bank Co.Ltd(000001) 6696289381 Baoshan sub branch 700 Shandong Yisheng Livestock & Poultry Breeding Co.Ltd(002458)
Shanghai Pudong Development Bank
Bank Co., Ltd. 98460078801 Shanghai Pudong Development Bank Co.Ltd(600000) 00000
Baoshan sub branch 500 Ja Solar Technology Co.Ltd(002459) 23179732149 Shanghai Pudong Development Bank
Bank Co., Ltd. 98460078801188798446870778921326 Baoshan sub branch China Vanke Co.Ltd(000002) 460
Wuxi Hequan
China Merchants Bank Co.Ltd(600036) Co., Ltd
Company (“Wuwu 5109 Shandong Wit Dyne Health Co.Ltd(000915) 1 – 802792570 Co., Ltd. Wuxi Branch Xihe General Pharmaceutical 0956
Industry “)
Shanghai Hequan
China Agricultural Bank Of China Limited(601288) shares Pharmaceutical Co., Ltd
109608 Shanghai Co., Ltd. 03857600040 – 6230120527 Jinshan sub branch (“Hequan”)
Pharmaceutical industry “)
Changzhou Hequan
China China Minsheng Banking Corp.Ltd(600016) stock Pharmaceutical Co., Ltd
Shanghai Branch Co., Ltd. (“Chang 632402943” not applicable – 6112558619 branch Zhouhe quanyao
Industry “)
China Merchants Bank Co.Ltd(600036) shares include Changzhou Hequan 12193694571 – 9391285755 Co., Ltd. Shanghai branch pharmaceutical 0590
Shanghai Hequan
Shanghai Pudong Development Bank pharmaceutical research and Development Co., Ltd
Bank Co., Ltd. 98460078801 – 727491279 Baoshan sub branch (“Hequan pharmaceutical 20 Guangxi Liugong Machinery Co.Ltd(000528)
